Skip to main
WAT

Waters (WAT) Stock Forecast & Price Target

Waters (WAT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 33%
Hold 28%
Sell 0%
Strong Sell 0%

Bulls say

Waters is poised for growth following their recent merger with Becton Dickinson's life science and diagnostics business. This acquisition has increased their concentration in diagnostics and discovery-related life science tools, and their analytical instruments are essential in developing and manufacturing products such as mRNA vaccines. Along with a strong product refresh and a potential for industry consolidation, Waters' financial flexibility, strong management team, and focus on sustainability position them well for future success.

Bears say

Waters is trading at a relatively high P/E ratio compared to its peers, and while the company has a strong organic growth outlook, there are concerns about its ability to effectively manage and integrate the recently acquired Becton Dickinson assets. With a potential slowdown in core growth and integration risks, Waters' multiple could come under pressure in the future. Additionally, there are concerns about the potential impact of market headwinds and funding on the company's Biosciences business, which could have a significant impact on its overall performance. However, the company has a strong management team with a track record of successfully turning around legacy assets and integrating large acquisitions.

Waters (WAT) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 33% recommend Buy, 28% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waters (WAT) Forecast

Analysts have given Waters (WAT) a Buy based on their latest research and market trends.

According to 18 analysts, Waters (WAT) has a Buy consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $426.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $426.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waters (WAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.